Tumor boards work — so why not an IBD board? A new multidisciplinary IBD Board launched at Cleveland Clinic handles difficult cases and helps patients find much-needed relief.
Bo Shen, MD, pioneered a technique that was formerly used only in the upper GI tract. It offers a more precise method for widening strictures than previous methods.
Register now for the Dr. Victor Fazio IBD Symposium in Medical and Surgical Treatment of Crohn’s Disease and Ulcerative Colitis on May 8.
A new behavioral medicine program in the Digestive Disease & Surgery Institute offers services ranging from preoperative care to dealing with conditions as irritable bowel syndrome and gastroparesis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
How well do functional medicine treatments help asthma patients? Cleveland Clinic’s Center for Functional Medicine is conducting research alongside experts from the Respiratory Institute to find out. This is one of a handful of studies underway at Cleveland Clinic to gather evidence-based data on functional medicine treatments.
Discover how a new application of a trusted endoscopic therapy is helping patients with inflammatory bowel disease enjoy relief from strictures and inflammation in the lower GI tract.
After demonstrating that breath analysis can detect pediatric nonalcoholic fatty liver disease, Cleveland Clinic Children’s is assessing the technique’s utility in diagnosing other pediatric gastrointestinal conditions.
Register now for this Aug. 7 CME event from Cleveland Clinic’s Digestive Disease Institute. Discover insights on treating inflammatory bowel disease in adult and pediatric patients.
With more than 5,000 initial and 500 reoperative pouch surgeries performed to-date, Cleveland Clinic’s Center for Ileal Pouch Disorders specializes in improving the quality of life of pouch patients from across the globe.
Meet new Cleveland Clinic researcher Dr. Huang, who recently joined Cleveland Clinic — bringing two five-year NIH RO1 grants to examine the pathogenesis of inflammatory-associated colorectal cancer.